CRMD

6.16

8.61% -0.58

Dopo l'orario di chiusura: 6.10 -0.06 -0.97%

CorMedix Inc (CRMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$6.74

Aprire:

$6.59

Volume 24 ore:

2.35M

Relative Volume:

1.76

Capitalizzazione di mercato:

$437.37M

Reddito:

$65,400

Utile/perdita netta:

$-46.34M

Rapporto P/E:

-6.6957

EPS:

-0.92

Flusso di cassa netto:

$-38.74M

1 W Prestazione:

-42.80%

1M Prestazione:

-40.54%

6M Prestazione:

-23.76%

1 anno Prestazione:

+45.28%

Intervallo 1D:

$6.09

$6.64

Intervallo di 1 settimana:

$6.09

$9.25

Portata 52W:

$3.61

$13.85

CorMedix Inc Stock (CRMD) Company Profile

Nome

CorMedix Inc

Settore

Healthcare (1164)

Industria

Biotechnology (681)

Telefono

908-517-9500

Indirizzo

400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ

Dipendente

Cinguettio

Prossima data di guadagno

2025-03-25

Ultimi documenti SEC

CRMD's Discussions on Twitter

Confronta CRMD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRMD CorMedix Inc	6.16	437.37M	65,400	-46.34M	-38.74M	-0.92
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-07	Iniziato	Leerink Partners	Outperform
2025-01-13	Iniziato	D. Boral Capital	Buy
2024-08-26	Iniziato	Rodman & Renshaw	Buy
2023-08-10	Iniziato	RBC Capital Mkts	Outperform
2021-02-17	Iniziato	Needham	Buy
2020-09-29	Iniziato	JMP Securities	Mkt Outperform
2020-09-21	Iniziato	Truist	Buy
2019-12-18	Iniziato	B. Riley FBR	Buy
2019-03-26	Reiterato	H.C. Wainwright	Buy
2018-12-06	Iniziato	ROTH Capital	Buy
2017-09-25	Reiterato	H.C. Wainwright	Buy
2017-08-10	Reiterato	Rodman & Renshaw	Buy
2017-05-05	Reiterato	Rodman & Renshaw	Buy
2016-11-11	Reiterato	FBR & Co.	Outperform
2016-03-17	Reiterato	FBR Capital	Outperform
2016-03-03	Iniziato	FBR Capital	Outperform
2015-11-16	Reiterato	ROTH Capital	Neutral
2015-10-29	Reiterato	ROTH Capital	Neutral
2015-05-06	Downgrade	ROTH Capital	Buy → Neutral
2014-12-08	Reiterato	ROTH Capital	Buy
2011-10-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

CorMedix Inc Borsa (CRMD) Ultime notizie

Mar 29, 2025

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of ... - Bluefield Daily Telegraph

Mar 27, 2025

Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value - Yahoo Finance

Mar 27, 2025

CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions - simplywall.st

Mar 27, 2025

CorMedix targets $50M-$60M revenue for H1 2025 with DefenCath growth - MSN

Mar 27, 2025

Mar 26, 2025

Lost Money on CorMedix Inc.(CRMD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 26, 2025

Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors - GlobeNewswire

Mar 26, 2025

The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD) - Seeking Alpha

Mar 26, 2025

CorMedix Inc (NASDAQ:CRMD) Order Delay - FXDailyReport.com

Mar 26, 2025

Long Term Trading Analysis for (CRMD) - Stock Traders Daily

Mar 26, 2025

INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC - GlobeNewswire

Mar 26, 2025